Delphia (Usa) Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Delphia (Usa) Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $217,009 - $257,408	310 Added 51.41%	913 $656,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $410,335 - $498,662	603 New	603 $495,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $353,137 - $475,812	-644 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $383,257 - $449,788	644 New	644 $450,000

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.